Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Paramount Sky (PSKY.US) is in negotiations with the Gulf Sovereign Wealth Fund to inject nearly $24 billion to support the acquisition of Warner Brothers Discovery (WBD.US).

The mediator for the Iran issue is making a final effort to reach a 45-day ceasefire agreement.

Bear market approaching! Tightening by central bank and pressure from Middle East conflict may further exacerbate the $95 billion drop in Indian bank stocks.
Paramount Sky (PSKY.US) is in negotiations with the Gulf Sovereign Wealth Fund to inject nearly $24 billion to support the acquisition of Warner Brothers Discovery (WBD.US).

The mediator for the Iran issue is making a final effort to reach a 45-day ceasefire agreement.

Bear market approaching! Tightening by central bank and pressure from Middle East conflict may further exacerbate the $95 billion drop in Indian bank stocks.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


